Contact PI/Project LeaderMARSHALL, SIMON ALEXANDER
Awardee OrganizationNORTH CAROLINA CENTRAL UNIVERSITY
Description
Abstract Text
Project Abstract: Excessive binge alcohol consumption causes major health and socio-economic issues within
the United States. Unfortunately, minorities in this country are disproportionately burdened by these problems
despite equal incidences of binge drinking. Finding ways to reduce binge like consumption therefore remains an
important field of research to combat health disparities and decrease the development of ethanol dependence.
This project seeks to determine if astrocytes and the neuroimmune system represent novel targets by which to
curb excessive consumption. This grant determines the influence of excessive ethanol on astrocytic activation
and function in the hippocampus as well if the proinflammatory cytokines are responsible for glial maladaptations
(Aim 1). Because sex-differences can alter neuroimmune responses, these studies will elucidate the impact of
sex on both astrocyte activation and their function. Secondly, these studies will determine if hippocampal
astrocytic signaling can be switched to reverse the influences of ethanol on the increased proinflammatory
microenvironment and decreased glutamatergic tone of the hippocampus (Aim 2). Finally, because both
glutamate and proinflammatory cytokines can impact hippocampal dependent memory tasks and consummatory
behaviors, these experiments will determine the impact of astrocytic signaling on ethanol consumption and
alcohol-induced cognitive deficits (Aim 2). The development of astrocyte specific DREADDs allows us to
manipulate G-protein coupled receptor signaling in the hippocampus using site directed stereotactic viral
delivery. Altogether, these two aims will test our overall hypothesis that there is a reciprocal and reinforcing
relationship between alcohol and astrocyte activation mediated by the influence of astrocytes on glutamatergic
tone and proinflammatory signaling cascades. These innovative studies will provide insight into the role of
astrocytes in the transition to alcohol dependence as well as the influence of alcohol-induced neuroimmune
dysregulation on the astrocytic response.
Public Health Relevance Statement
NARRATIVE:
The current treatments for alcohol use disorders are not universally effective, so determining
new therapeutic areas is of critical concern. Astrocytes, key regulators of the neuroimmune
response and neurotransmission, represent a novel target by which to reduce excessive alcohol
consumption. The results of the current study will explore the viability of reducing binge drinking
and cognitive deficits through manipulating astrocytic regulations of neuroimmune and
glutamate signaling.
National Institute on Alcohol Abuse and Alcoholism
CFDA Code
DUNS Number
783691801
UEI
L1DXXP1KGP77
Project Start Date
20-September-2022
Project End Date
31-August-2027
Budget Start Date
01-September-2024
Budget End Date
31-August-2025
Project Funding Information for 2024
Total Funding
$189,152
Direct Costs
$126,101
Indirect Costs
$63,051
Year
Funding IC
FY Total Cost by IC
2024
National Institute on Alcohol Abuse and Alcoholism
$189,152
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 5U54AA030451-03 9109
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5U54AA030451-03 9109
Patents
No Patents information available for 5U54AA030451-03 9109
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5U54AA030451-03 9109
Clinical Studies
No Clinical Studies information available for 5U54AA030451-03 9109
News and More
Related News Releases
No news release information available for 5U54AA030451-03 9109
History
No Historical information available for 5U54AA030451-03 9109
Similar Projects
No Similar Projects information available for 5U54AA030451-03 9109